These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 26608483)

  • 1. Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia.
    Schnabel R; Fijten R; Smolinska A; Dallinga J; Boumans ML; Stobberingh E; Boots A; Roekaerts P; Bergmans D; van Schooten FJ
    Sci Rep; 2015 Nov; 5():17179. PubMed ID: 26608483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic nose analysis of exhaled breath to diagnose ventilator-associated pneumonia.
    Schnabel RM; Boumans ML; Smolinska A; Stobberingh EE; Kaufmann R; Roekaerts PM; Bergmans DC
    Respir Med; 2015 Nov; 109(11):1454-9. PubMed ID: 26440675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Detection of Ventilator-associated Pneumonia From Exhaled Breath in Intensive Care Unit Patients.
    Bakali U; Killawala C; Monteagudo E; Cobler-Lichter MD; Tito L; Delamater J; Shagabayeva L; Collie BL; Lyons NB; Dikici E; Deo SK; Daunert S; Schulman CI
    Ann Surg; 2024 Sep; 280(3):394-402. PubMed ID: 38920028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BreathDx - molecular analysis of exhaled breath as a diagnostic test for ventilator-associated pneumonia: protocol for a European multicentre observational study.
    van Oort PM; Nijsen T; Weda H; Knobel H; Dark P; Felton T; Rattray NJ; Lawal O; Ahmed W; Portsmouth C; Sterk PJ; Schultz MJ; Zakharkina T; Artigas A; Povoa P; Martin-Loeches I; Fowler SJ; Bos LD;
    BMC Pulm Med; 2017 Jan; 17(1):1. PubMed ID: 28049457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled Breath Metabolomics for the Diagnosis of Pneumonia in Intubated and Mechanically-Ventilated Intensive Care Unit (ICU)-Patients.
    van Oort PM; de Bruin S; Weda H; Knobel HH; Schultz MJ; Bos LD; On Behalf Of The Mars Consortium
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breath analysis for in vivo detection of pathogens related to ventilator-associated pneumonia in intensive care patients: a prospective pilot study.
    Filipiak W; Beer R; Sponring A; Filipiak A; Ager C; Schiefecker A; Lanthaler S; Helbok R; Nagl M; Troppmair J; Amann A
    J Breath Res; 2015 Jan; 9(1):016004. PubMed ID: 25557917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breath analysis for noninvasively differentiating Acinetobacter baumannii ventilator-associated pneumonia from its respiratory tract colonization of ventilated patients.
    Gao J; Zou Y; Wang Y; Wang F; Lang L; Wang P; Zhou Y; Ying K
    J Breath Res; 2016 Jun; 10(2):027102. PubMed ID: 27272697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of exhaled breath to identify critically ill patients with ventilator-associated pneumonia.
    Felton TW; Ahmed W; White IR; van Oort P; Rattray NJW; Docherty C; Bannard-Smith J; Morton B; Welters I; McMullan R; Roberts SA; Goodacre R; Dark PM; Fowler SJ
    Anaesthesia; 2023 Jun; 78(6):712-721. PubMed ID: 37010959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of the noninvasive assessment of the lung microbiota as a potential tool for the early diagnosis of ventilator-associated pneumonia.
    May AK; Brady JS; Romano-Keeler J; Drake WP; Norris PR; Jenkins JM; Isaacs RJ; Boczko EM
    Chest; 2015 Jun; 147(6):1494-1502. PubMed ID: 25474571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can exhaled volatile organic compounds predict asthma exacerbations in children?
    van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
    J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for lower airway pathogens in mechanically ventilated patients by metabolomic analysis of exhaled breath: a case-control study.
    Fowler SJ; Basanta-Sanchez M; Xu Y; Goodacre R; Dark PM
    Thorax; 2015 Apr; 70(4):320-5. PubMed ID: 25661115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.
    Smolinska A; Klaassen EM; Dallinga JW; van de Kant KD; Jobsis Q; Moonen EJ; van Schayck OC; Dompeling E; van Schooten FJ
    PLoS One; 2014; 9(4):e95668. PubMed ID: 24752575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.
    van Mastrigt E; Reyes-Reyes A; Brand K; Bhattacharya N; Urbach HP; Stubbs AP; de Jongste JC; Pijnenburg MW
    J Breath Res; 2016 Apr; 10(2):026003. PubMed ID: 27058305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Headspace volatile organic compounds from bacteria implicated in ventilator-associated pneumonia analysed by TD-GC/MS.
    Lawal O; Muhamadali H; Ahmed WM; White IR; Nijsen TME; Goodacre R; Fowler SJ
    J Breath Res; 2018 Jan; 12(2):026002. PubMed ID: 28947683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.